The role of oral ferric pyrophosphate protected by a phospholipid bilayer plus a sucrester matrix for treating cancer-related anemia.

Barni S, Brilli E, Tarantino G, Munoz M

Open source

DOI
10.1080/17474086.2025.2541005
Published
2025 Nov
Container
Expert review of hematology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17474086.2025.2541005,
  title = {The role of oral ferric pyrophosphate protected by a phospholipid bilayer plus a sucrester matrix for treating cancer-related anemia.},
  author = {Barni S and Brilli E and Tarantino G and Munoz M},
  year = {2025},
  journal = {Expert review of hematology},
  doi = {10.1080/17474086.2025.2541005},
  url = {https://doi.org/10.1080/17474086.2025.2541005}
}

RIS

TY  - JOUR
TI  - The role of oral ferric pyrophosphate protected by a phospholipid bilayer plus a sucrester matrix for treating cancer-related anemia.
AU  - Barni S
AU  - Brilli E
AU  - Tarantino G
AU  - Munoz M
PY  - 2025
JO  - Expert review of hematology
DO  - 10.1080/17474086.2025.2541005
UR  - https://doi.org/10.1080/17474086.2025.2541005
ER  - 

APA

S, B., E, B., G, T., & M, M. (2025). The role of oral ferric pyrophosphate protected by a phospholipid bilayer plus a sucrester matrix for treating cancer-related anemia.. Expert review of hematology. https://doi.org/10.1080/17474086.2025.2541005

Source records